MCHALE DUNCAN (Chief Medical Officer) sold 33.5% of their position (6.85K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $2.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/3/2023ACC: 0001694665-23-000168
Officer· Chief Medical Officer
Since Jan 2020
-6.85K
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 19.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
157.4%
11/1/2023
7.94K→20.44K
Common Stock
Direct
Shares
−6.85K
Price / share
$0.33
Trade value
$2.26K
% of position
33.5%
11/2/2023
20.44K→13.59K
Total
Net shares
+5.65K
Net value
-$2.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2023 | M · Option Exercise | +12.50K | — | — | 157.4% | 7.94K | 20.44K |
| Common Stock Direct | 11/2/2023 | S · Sale | −6.85K | $0.33 | $2.26K | 33.5% | 20.44K | 13.59K |
| Total | +5.65K | -$2.26K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
Held after
25K
Exercisable
—
11/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock12.50K shares | 11/1/2023 | M · Option Exercise | −12.50K | — | 25K |